|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (5Y Monthly)||1.14|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 15, 2023 - May 19, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
RICHARDSON, Texas, November 15, 2022--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission ("SEC") on November 14, 2022.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Velocys plc ( LON:VLS...